• FirefoxInstall the new Firefox »
  •  Dow Up 0.21% Nasdaq Up 0.32%

    Cyclacel Pharmaceuticals, Inc. (CYCC)

    -NasdaqGM
    1.06 Down 0.04(3.64%) 4:00PM EST
    Add to Portfolio
    Prev Close:1.10
    Open:1.10
    Bid:1.01 x 2100
    Ask:1.09 x 2500
    1y Target Est:9.00
    Beta:3.4
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:1.03 - 1.12
    52wk Range:0.51 - 4.14
    Volume:1,359,598
    Avg Vol (3m):1,101,550
    Market Cap:24.35M
    P/E (ttm):N/A
    EPS (ttm):-0.88
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CYCC

    Comparison

    Symbol% ChgMkt Cap
    CYCCDown 3.64%24.35M
    AZNUp 0.58%86.11B
    JNJUp 0.86%285.06B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):14.15
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.96
    Quarterly EPS Est (Dec-14) :-0.26
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, develops and commercializes mechanism-targeted drugs to treat human cancers and other serious diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback